RJA
MJN

Raymond James & Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

Raymond James & Associates’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,090
Closed -$1.08M – 3502
2017
Q1 		$1.08M Sell
12,090
-61,455
-84% -$5.05M ﹤0.01% 1931
2016
Q4 		$5.2M Sell
73,545
-14,531
-16% -$1.08M 0.01% 973
2016
Q3 		$6.96M Sell
88,076
-5,420
-6% -$462K 0.02% 775
2016
Q2 		$8.48M Buy
93,496
+1,842
+2% +$156K 0.03% 612
2016
Q1 		$7.79M Sell
91,654
-537
-0.6% -$39.9K 0.03% 613
2015
Q4 		$7.28M Buy
92,191
+73,684
+398% +$5.8M 0.03% 637
2015
Q3 		$1.3M Sell
18,507
-2,606
-12% -$214K 0.01% 1455
2015
Q2 		$1.91M Sell
21,113
-19,488
-48% -$1.88M 0.01% 1351
2015
Q1 		$4.08M Buy
40,601
+3,253
+9% +$328K 0.02% 853
2014
Q4 		$3.75M Sell
37,348
-25,592
-41% -$2.55M 0.02% 818
2014
Q3 		$6.06M Buy
62,940
+10
+0% +$948 0.03% 540
2014
Q2 		$5.86M Sell
62,930
-225
-0.4% -$19.7K 0.04% 564
2014
Q1 		$5.25M Buy
63,155
+7,914
+14% +$642K 0.04% 552
2013
Q4 		$4.63M Buy
55,241
+9,618
+21% +$783K 0.03% 564
2013
Q3 		$3.39M Buy
45,623
+15,451
+51% +$1.16M 0.03% 633
2013
Q2 		$2.39M Buy
+30,172
New +$2.42M 0.02% 721

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Raymond James & Associates's MJN Position: Q2 2017 in Review

Raymond James & Associates sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 12,090 shares — an estimated $1.08M sold.

Raymond James & Associates first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $8.48M in Q2 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Raymond James & Associates reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Raymond James & Associates sold 12,090 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $1.08M.
  • Raymond James & Associates first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Raymond James & Associates's Mead Johnson Nutrition Company position peaked at $8.48M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.